Bajaj, Jeevisha http://orcid.org/0000-0002-8411-6056
Hamilton, Michael
Shima, Yutaka
Chambers, Kendall
Spinler, Kyle
Van Nostrand, Eric L.
Yee, Brian A. http://orcid.org/0000-0001-5615-8550
Blue, Steven M. http://orcid.org/0000-0003-0279-6690
Chen, Michael
Rizzeri, David
Chuah, Charles
Oehler, Vivian G.
Broome, H. Elizabeth
Sasik, Roman
Scott-Browne, James
Rao, Anjana http://orcid.org/0000-0002-1870-1775
Yeo, Gene W. http://orcid.org/0000-0002-0799-6037
Reya, Tannishtha http://orcid.org/0000-0002-5956-8536
Funding for this research was provided by:
American Society of Hematology (Scholar Award)
U.S. Department of Health & Human Services | NIH | Center for Scientific Review (T32HL086344, T32HL086344, R35 CA210043, U41HG009889)
Damon Runyon Cancer Research Foundation
U.S. Department of Health & Human Services | NIH | Center for Information Technology (HG009530, DK099335, U54HG007005)
Article History
Received: 18 July 2019
Accepted: 13 March 2020
First Online: 20 April 2020
Competing interests
: G.W.Y. is co-founder, member of the Board of Directors, on the SAB, equity holder and paid consultant for Locana and Eclipse BioInnovations. G.W.Y. is also a visiting professor at the National University of Singapore and receives travel reimbursement. E.L.V.N. is co-founder, member of the Board of Directors, on the SAB, equity holder and paid consultant for Eclipse BioInnovations. G.W.Y.’s and E.L.V.N.’s interests have been reviewed and approved by the University of California San Diego in accordance with its conflict of interest policies.